Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1050)	1/25/2006 4:02:58 PM
From: nigel bates	Read Replies (1) \| Respond to of 1255

wasn't posting that to criticize performance I know - mine was purely a glib comparison. Fun, though - also if you add TELK and EXEL to the 2 vs 5 year views (haven't played around with this for a while, but it certainly validates your approach vs. buy'n'hold...).

To: scaram(o)uche who wrote (1050)	1/25/2006 4:14:19 PM
From: scaram(o)uche	Respond to of 1255

>> haven't followed the company closely until just recently << Actually, I interviewed to be the company's first V.P., R&D. So I followed the company closely for years, but then lost contact for many more. Many years of base-building. A scientist who I was involved in bringing to Bayer, and who I subsequently hired at a biotech? She headed the monoclonal development team at GenPharm. Message 2077155 Message 8403906 Message 8067579 etc. So I knew the company inside and out, from origin to the transition away from bifunctional MAbs. Enormous leverage, but glad that I didn't ride along.